Suppr超能文献

印度旁遮普邦结核分枝杆菌分离株的多药耐药性和突变频率。

Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.

机构信息

Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.

Department of Tuberculosis and Respiratory Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.

出版信息

J Epidemiol Glob Health. 2017 Sep;7(3):175-180. doi: 10.1016/j.jegh.2017.05.002. Epub 2017 May 24.

Abstract

Data regarding prevalence of multi-drug resistant tuberculosis (MDR-TB) and associated common mutations is scarce from Punjab region. The study was designed to determine rate of MDR-TB among presumptive MDR-TB from Punjab and mutation patterns using GenoType MTBDRplus assay. Total of 812 consecutive sputum samples were received from January 2012 to July 2013, from 14 districts of Punjab at the National Reference Laboratory at New Delhi for diagnosis of MDR-TB as hand holding activity. Presumptive MDR-TB patients were identified on basis of criterion B defined by the programme. Smear positive and negatives patients were found to be 636/798 (79.7%) and 162/ 798 (20.3%) respectively. Total of 606 GenoType MTBDRplus tests were conducted and mutations in rpoB, kat G and inhA genes analyzed. Total of 94/606 (15.5%), 43/606 (7.1%) and 40/606 (6.6%) were found to be RIF and INH resistant, mono-RIF resistant and 40/606 (6.6%) mono-INH resistant respectively. Commonest known mutation for RIF in rpoB gene and INH in kat G gene was S531L (80/ 137; 58.4%) and S315T1 (119/134; 88.8%) respectively. Mutations in inhA were found in 21/134 (15.7%) strains. Average turn-around time (TAT) for dispatch of result toPunjab was 4.6days. Prevalence of RIF resistance in Punjab was found to be 22.6%. Common mutations for RIF and INH were similar to that in other regions of country. GenoType MTBDRplus was found to be useful assay for rapid detection of MDR-TB, responsible for determining better management of MDR-TB patients under the programme.

摘要

来自旁遮普地区的关于耐多药结核病(MDR-TB)的流行率和相关常见突变的数据很少。本研究旨在确定旁遮普邦疑似 MDR-TB 患者中的 MDR-TB 发生率,并使用 GenoType MTBDRplus 检测分析其突变模式。2012 年 1 月至 2013 年 7 月,共有 812 例连续痰液样本从旁遮普邦的 14 个区送到新德里的国家参考实验室,作为 HAND HOLDING 活动来诊断 MDR-TB。根据该计划定义的标准 B 确定疑似 MDR-TB 患者。涂片阳性和涂片阴性患者分别为 636/798(79.7%)和 162/798(20.3%)。共进行了 606 次 GenoType MTBDRplus 检测,并分析了 rpoB、katG 和 inhA 基因的突变。结果发现,606 例中有 94/606(15.5%)、43/606(7.1%)和 40/606(6.6%)对利福平(RIF)和异烟肼(INH)耐药、单利福平耐药和单异烟肼耐药,rpoB 基因中常见的利福平耐药突变和 katG 基因中常见的异烟肼耐药突变分别为 S531L(80/137;58.4%)和 S315T1(119/134;88.8%)。inhA 中的突变见于 134 株菌株中的 21 株(15.7%)。将结果发送到旁遮普邦的平均周转时间(TAT)为 4.6 天。在旁遮普邦发现利福平耐药率为 22.6%。利福平(RIF)和异烟肼(INH)的常见突变与该国其他地区的相似。GenoType MTBDRplus 被发现是一种快速检测 MDR-TB 的有用检测方法,有助于确定该计划下 MDR-TB 患者的更好管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b22/7320448/31cfde4da2f6/JEGH-7-3-175-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验